Skip to main content

16.03.2024 | Review Article

Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus Guidelines

verfasst von: Lata Singh, Girish Chinnaswamy, Rachna Meel, Venkatraman Radhakrishnan, Renu Madan, Suyash Kulkarni, Archana Sasi, Tanvir Kaur, R. S. Dhaliwal, Sameer Bakhshi

Erschienen in: Indian Journal of Pediatrics

Einloggen, um Zugang zu erhalten

Abstract

Retinoblastoma (RB) is the most common intraocular tumor in childhood. It is mainly caused by mutations in both alleles of the RB1 tumor suppressor gene that is found on chromosome 13 and regulates the cell cycle. Approximately 8000 children are diagnosed with RB globally each year, with an estimated 1500 cases occurring in India. The survival rate of RB has improved to more than 90% in the developed world. Leukocoria and proptosis are the most common presenting features of RB in Asian Indian populations. Most cases of RB are diagnosed by fundus examination followed by ultrasound. The International Classification of Retinoblastoma is the most used scheme for the staging and classification of intraocular RB in India. Prenatal testing and preimplantation genetic testing for RB may be beneficial in high-risk families. Histopathologic risk factors such as massive choroidal invasion and post-laminar optic nerve help in predicting the occurrence of metastasis in children with RB, while presence of microscopic residual disease requires aggressive adjuvant treatment in eyes enucleated for group E RB. The review provides a consensus document on diagnosis and genetics of RB in India.
Literatur
1.
Zurück zum Zitat Arora R, Eden T, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46:264–73.CrossRefPubMed Arora R, Eden T, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer. 2009;46:264–73.CrossRefPubMed
2.
Zurück zum Zitat Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93:24–7.CrossRefPubMed Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93:24–7.CrossRefPubMed
4.
5.
Zurück zum Zitat Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31.CrossRefPubMed Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31.CrossRefPubMed
6.
Zurück zum Zitat Gupta N, Pandey A, Dimri K, Prinja S. Epidemiological profile of retinoblastoma in North India: implications for primary care and family physicians. J Family Med Prim Care. 2020;9:2843–8.CrossRefPubMedPubMedCentral Gupta N, Pandey A, Dimri K, Prinja S. Epidemiological profile of retinoblastoma in North India: implications for primary care and family physicians. J Family Med Prim Care. 2020;9:2843–8.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Ries LAG, Smith MA, Gurney JG, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995. Bethesda, MD: National Cancer Institute, SEER Program. NIH Pub. No. 99-4649;1999. Ries LAG, Smith MA, Gurney JG, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995. Bethesda, MD: National Cancer Institute, SEER Program. NIH Pub. No. 99-4649;1999.
9.
Zurück zum Zitat Bakhshi S, Bakhshi R. Genetics and management of retinoblastoma. J Indian Assoc Pediatr Surg. 2007;12:109–15.CrossRef Bakhshi S, Bakhshi R. Genetics and management of retinoblastoma. J Indian Assoc Pediatr Surg. 2007;12:109–15.CrossRef
10.
Zurück zum Zitat Kapoor G, Arora RS, Radhakrishnan V, et al. Profile of childhood cancers from hospital-based cancer registries in India, 2012-19. Indian Pediatr. 2024;61:39–44.CrossRefPubMed Kapoor G, Arora RS, Radhakrishnan V, et al. Profile of childhood cancers from hospital-based cancer registries in India, 2012-19. Indian Pediatr. 2024;61:39–44.CrossRefPubMed
13.
Zurück zum Zitat Meel R, Radhakrishnan V, Bakhshi S. Current therapy and recent advances in the management of retinoblastoma. Indian J Med Paediatr Oncol. 2012;33:80–8.CrossRefPubMedPubMedCentral Meel R, Radhakrishnan V, Bakhshi S. Current therapy and recent advances in the management of retinoblastoma. Indian J Med Paediatr Oncol. 2012;33:80–8.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Malhotra RK, Manoharan N, Nair O, Deo SVS, Bakhshi S, Rath GK. Patterns and trends of childhood cancer incidence (0–14 years) in Delhi, India: 1990–2014. Indian Pediatr. 2021;58:430–5.CrossRefPubMed Malhotra RK, Manoharan N, Nair O, Deo SVS, Bakhshi S, Rath GK. Patterns and trends of childhood cancer incidence (0–14 years) in Delhi, India: 1990–2014. Indian Pediatr. 2021;58:430–5.CrossRefPubMed
15.
Zurück zum Zitat Bakhshi S, Gupta S, Gogia V, Ravindranath Y. Compliance in retinoblastoma. Indian J Pediatr. 2010;77:535–40.CrossRefPubMed Bakhshi S, Gupta S, Gogia V, Ravindranath Y. Compliance in retinoblastoma. Indian J Pediatr. 2010;77:535–40.CrossRefPubMed
16.
Zurück zum Zitat Chawla B, Hasan F, Azad R, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2016;100:172–8.CrossRefPubMed Chawla B, Hasan F, Azad R, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2016;100:172–8.CrossRefPubMed
18.
Zurück zum Zitat Kleinerman RA, Yu CL, Little MP, et al. Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol. 2012;30:950–7.CrossRefPubMedPubMedCentral Kleinerman RA, Yu CL, Little MP, et al. Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol. 2012;30:950–7.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Nichols KE, Walther S, Chao E, Shields C, Ganguly A. Recent advances in retinoblastoma genetic research. Curr Opin Ophthalmol. 2009;20:351–5.CrossRefPubMed Nichols KE, Walther S, Chao E, Shields C, Ganguly A. Recent advances in retinoblastoma genetic research. Curr Opin Ophthalmol. 2009;20:351–5.CrossRefPubMed
20.
Zurück zum Zitat Benavente CA, Dyer MA. Genetics and epigenetics of human retinoblastoma. Annu Rev Pathol. 2015;10:547–62.CrossRefPubMed Benavente CA, Dyer MA. Genetics and epigenetics of human retinoblastoma. Annu Rev Pathol. 2015;10:547–62.CrossRefPubMed
21.
Zurück zum Zitat Rushlow DE, Mol BM, Kennett JY, et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol. 2013;14:327–34.CrossRefPubMed Rushlow DE, Mol BM, Kennett JY, et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol. 2013;14:327–34.CrossRefPubMed
22.
Zurück zum Zitat Haik BG, Dunleavy SA, Cooke C, et al. Retinoblastoma with anterior chamber extension. Ophthalmology. 1987;94:367–70.CrossRefPubMed Haik BG, Dunleavy SA, Cooke C, et al. Retinoblastoma with anterior chamber extension. Ophthalmology. 1987;94:367–70.CrossRefPubMed
23.
Zurück zum Zitat Kaliki S, Shields CL, Cassoux N, et al. Defining high-risk retinoblastoma: a multicenter global survey. JAMA Ophthalmol. 2022;140:30–6.CrossRefPubMed Kaliki S, Shields CL, Cassoux N, et al. Defining high-risk retinoblastoma: a multicenter global survey. JAMA Ophthalmol. 2022;140:30–6.CrossRefPubMed
24.
Zurück zum Zitat Kashyap S, Sethi S, Meel R, et al. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country. Arch Pathol Lab Med. 2012;136:190–3.CrossRefPubMed Kashyap S, Sethi S, Meel R, et al. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country. Arch Pathol Lab Med. 2012;136:190–3.CrossRefPubMed
25.
Zurück zum Zitat Kaliki S, Srinivasan V, Gupta A, Mishra DK, Naik MN. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study. Ophthalmology. 2015;122:1165–72.CrossRefPubMed Kaliki S, Srinivasan V, Gupta A, Mishra DK, Naik MN. Clinical features predictive of high-risk retinoblastoma in 403 Asian Indian patients: a case-control study. Ophthalmology. 2015;122:1165–72.CrossRefPubMed
26.
Zurück zum Zitat Sastre X, Chantada GL, Doz F, et al. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009;133:1199–202.CrossRefPubMed Sastre X, Chantada GL, Doz F, et al. Proceedings of the consensus meetings from the International Retinoblastoma Staging Working Group on the pathology guidelines for the examination of enucleated eyes and evaluation of prognostic risk factors in retinoblastoma. Arch Pathol Lab Med. 2009;133:1199–202.CrossRefPubMed
27.
Zurück zum Zitat Singh L, Singh MK, Rizvi MA, et al. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma. Cancer Immunol Immunother. 2020;69:1087–99.CrossRefPubMed Singh L, Singh MK, Rizvi MA, et al. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma. Cancer Immunol Immunother. 2020;69:1087–99.CrossRefPubMed
28.
Zurück zum Zitat López López JC, Fernández Alonso N, Cuevas Álvarez J, García-Caballero T, Pastor Jimeno JC. Immunohistochemical assay for neuron-specific enolase, synaptophysin, and RB-associated protein as a diagnostic aid in advanced retinoblastomas. Clin Ophthalmol. 2018;12:1171–9.CrossRefPubMedPubMedCentral López López JC, Fernández Alonso N, Cuevas Álvarez J, García-Caballero T, Pastor Jimeno JC. Immunohistochemical assay for neuron-specific enolase, synaptophysin, and RB-associated protein as a diagnostic aid in advanced retinoblastomas. Clin Ophthalmol. 2018;12:1171–9.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Radhakrishnan V, Kashyap S, Singh L, Pushker N, Bakhshi S. Prognostic significance of VEGF at baseline in orbital retinoblastoma (IRSS stage II and stage III). Pediatr Blood Cancer. 2012;59:769–70.CrossRefPubMed Radhakrishnan V, Kashyap S, Singh L, Pushker N, Bakhshi S. Prognostic significance of VEGF at baseline in orbital retinoblastoma (IRSS stage II and stage III). Pediatr Blood Cancer. 2012;59:769–70.CrossRefPubMed
30.
Zurück zum Zitat Kashyap S, Meel R, Pushker N, et al. Clinical predictors of high risk histopathology in retinoblastoma. Pediatr Blood Cancer. 2012;58:356–61.CrossRefPubMed Kashyap S, Meel R, Pushker N, et al. Clinical predictors of high risk histopathology in retinoblastoma. Pediatr Blood Cancer. 2012;58:356–61.CrossRefPubMed
31.
Zurück zum Zitat de Graaf P, Göricke S, Rodjan F, et al. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012;42:2–14.CrossRefPubMed de Graaf P, Göricke S, Rodjan F, et al. Guidelines for imaging retinoblastoma: imaging principles and MRI standardization. Pediatr Radiol. 2012;42:2–14.CrossRefPubMed
32.
Zurück zum Zitat Beets-Tan RG, Hendriks MJ, Ramos LM, Tan KE. Retinoblastoma: CT and MRI. Neuroradiology. 1994;36:59–62.CrossRefPubMed Beets-Tan RG, Hendriks MJ, Ramos LM, Tan KE. Retinoblastoma: CT and MRI. Neuroradiology. 1994;36:59–62.CrossRefPubMed
33.
Zurück zum Zitat Tomar AS, Finger PT, Gallie B, et al; American Joint Committee on Cancer Ophthalmic Oncology Task Force; American Joint Committee on Cancer Ophthalmic Oncology Task. Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging. Br J Ophthalmol. 2023;107:127–32. Tomar AS, Finger PT, Gallie B, et al; American Joint Committee on Cancer Ophthalmic Oncology Task Force; American Joint Committee on Cancer Ophthalmic Oncology Task. Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging. Br J Ophthalmol. 2023;107:127–32.
34.
Zurück zum Zitat Bakhshi S, Meel R, Kashyap S, Sharma S. Bone marrow aspirations and lumbar punctures in retinoblastoma at diagnosis: correlation with IRSS staging. J Pediatr Hematol Oncol. 2011;33:e182–5.CrossRefPubMed Bakhshi S, Meel R, Kashyap S, Sharma S. Bone marrow aspirations and lumbar punctures in retinoblastoma at diagnosis: correlation with IRSS staging. J Pediatr Hematol Oncol. 2011;33:e182–5.CrossRefPubMed
35.
Zurück zum Zitat de Jong MC, Kors WA, de Graaf P, Castelijns JA, Kivelä T, Moll AC. Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1157–67.CrossRefPubMed de Jong MC, Kors WA, de Graaf P, Castelijns JA, Kivelä T, Moll AC. Trilateral retinoblastoma: a systematic review and meta-analysis. Lancet Oncol. 2014;15:1157–67.CrossRefPubMed
36.
Zurück zum Zitat Kamihara J, Bourdeaut F, Foulkes WD, et al. Retinoblastoma and neuroblastoma predisposition and surveillance. Clin Cancer Res. 2017;23:e98–106.CrossRefPubMedPubMedCentral Kamihara J, Bourdeaut F, Foulkes WD, et al. Retinoblastoma and neuroblastoma predisposition and surveillance. Clin Cancer Res. 2017;23:e98–106.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Sethi RV, Shih HA, Yeap BY, et al. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 2014;120:126–33.CrossRefPubMed Sethi RV, Shih HA, Yeap BY, et al. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 2014;120:126–33.CrossRefPubMed
38.
Zurück zum Zitat Mallipatna A, Marino M, Singh AD. Genetics of retinoblastoma. Asia Pac J Ophthalmol. 2016;5:260–4.CrossRef Mallipatna A, Marino M, Singh AD. Genetics of retinoblastoma. Asia Pac J Ophthalmol. 2016;5:260–4.CrossRef
39.
Zurück zum Zitat Singh L, Saini N, Pushker N, et al. Mutational analysis of the mitochondrial DNA displacement-loop region in human retinoblastoma with patient outcome. Pathol Oncol Res. 2019;25:503–12.CrossRefPubMed Singh L, Saini N, Pushker N, et al. Mutational analysis of the mitochondrial DNA displacement-loop region in human retinoblastoma with patient outcome. Pathol Oncol Res. 2019;25:503–12.CrossRefPubMed
40.
Zurück zum Zitat Grotta S, D’Elia G, Scavelli R, et al. Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma. BMC Cancer. 2015;15:841.CrossRefPubMedPubMedCentral Grotta S, D’Elia G, Scavelli R, et al. Advantages of a next generation sequencing targeted approach for the molecular diagnosis of retinoblastoma. BMC Cancer. 2015;15:841.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Neriyanuri S, Raman R, Rishi P, Govindasamy K, Ramprasad VL, Sharma T. Prenatal genetic diagnosis of retinoblastoma–clinical correlates on follow-up. Indian J Ophthalmol. 2015;63:741–2.CrossRefPubMedPubMedCentral Neriyanuri S, Raman R, Rishi P, Govindasamy K, Ramprasad VL, Sharma T. Prenatal genetic diagnosis of retinoblastoma–clinical correlates on follow-up. Indian J Ophthalmol. 2015;63:741–2.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Malhotra J, Malhotra K, Majumdar G, et al. Indian Society for Assisted Reproduction consensus guidelines on preimplantation genetic testing in in vitro fertilization clinics. J Hum Reprod Sci. 2021;14:S31–47. Malhotra J, Malhotra K, Majumdar G, et al. Indian Society for Assisted Reproduction consensus guidelines on preimplantation genetic testing in in vitro fertilization clinics. J Hum Reprod Sci. 2021;14:S31–47.
44.
Zurück zum Zitat Soliman SE, Racher H, Zhang C, MacDonald H, Gallie BL. Genetics and molecular diagnostics in retinoblastoma–an update. Asia Pac J Ophthalmol. 2017;6:197–207. Soliman SE, Racher H, Zhang C, MacDonald H, Gallie BL. Genetics and molecular diagnostics in retinoblastoma–an update. Asia Pac J Ophthalmol. 2017;6:197–207.
Metadaten
Titel
Epidemiology, Diagnosis and Genetics of Retinoblastoma: ICMR Consensus Guidelines
verfasst von
Lata Singh
Girish Chinnaswamy
Rachna Meel
Venkatraman Radhakrishnan
Renu Madan
Suyash Kulkarni
Archana Sasi
Tanvir Kaur
R. S. Dhaliwal
Sameer Bakhshi
Publikationsdatum
16.03.2024
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-024-05085-2

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.